Biological agents targeting against a series of pro-inflammatory cytokines have provided an enormous impact on the therapeutic management on inflammatory disorders such as rheumatoid arthritis. Clinical development of biological agents in Japan, particularly, TNF inhibitors, has been reviewed in this paper, and future perspective is discussed.
|Number of pages||4|
|Journal||Nippon rinsho. Japanese journal of clinical medicine|
|Publication status||Published - 2007 Jul|
ASJC Scopus subject areas